- Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall CNBC
- Pfizer Stock Rises After Earnings Beat. Trump Tariffs Uncertainty Remains. Barron’s
- Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales with COVID infections in retreat MarketWatch
- Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance Business Wire
- Pfizer disappoints in first quarter earnings, faces several headwinds Yahoo Finance